Regeneus Ltd. (AU:CMB) has released an update.
Cambium Bio Limited has announced the successful approval of a share consolidation during their general meeting on June 25, 2024. The consolidation process is scheduled to commence on July 2, 2024, with key dates provided for shareholder reference, although these are subject to change. Shareholders can expect updates to their holdings following the completion of the consolidation.
For further insights into AU:CMB stock, check out TipRanks’ Stock Analysis page.
